Parkinson's Disease Treatment Market : Top Industry Player's Growth and Strategies

The Parkinson’s disease treatment market is fragmented in nature due to the presence of a large number of players. The key players are Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), and Boehringer Ingelheim (Germany).

Expansions, acquisitions, agreements, and product launches were the key strategies followed by players in the Parkinson’s disease treatment market. 

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247

AbbVie is a key player in the Parkinson’s disease treatment market. The company focuses on organic growth to strengthen its positon in the market. For instance, in 2015, the company launched Duopa drug for treating Parkinson’s disease.

Teva is one of the key players in the Parkinson’s disease treatment market. The company focuses on organic and inorganic strategies to strengthen its position in the Parkinson’s disease treatment market. For instance, in 2015, the company entered into an agreement with Takeda pharmaceutical company to commercialize rasagiline tablets in the Japan.  

Boehringer Ingelheim is another major player in the Parkinson’s disease treatment market. The company mainly focuses on organic strategies to strengthen its position in the market. In 2015, The company launched a new R&D strategy for the fiscal years 2015–2020. 

The Parkinson’s disease treatment market is projected to reach USD 5.69 Billion by 2022 from an estimated USD 4.24 Billion in 2017, at a CAGR of 6.1%. The major factors driving the growth of this market are Growth in the aging population and the associated increase in the prevalence of Parkinson’s disease and growing government funding and support for research

To Know More @https://www.marketsandmarkets.com/Market-Reports/parkinson-disease-treatment-market-47265247.html

Top Industry Players of Global Healthcare Quality Management Market

The global healthcare quality management market is projected to reach USD 3.31 Billion by 2022 from an estimated USD 1.70 Billion in 2017, at a CAGR of 14.2%.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64588778

In 2016, Nuance Communications, Inc. (U.S.), Premier, Inc. (U.S.), Truven Health Analytics (U.S.), Quantros, Inc. (U.S.), and Medisolv, Inc. (U.S.) dominated the market.

Nuance Communication, Inc. dominated the global healthcare quality management market in 2016. Nuance’s leading position in the market can be attributed to the wide range of its product portfolio. The company’s quality and risk management solutions include physician quality reporting solutions, eCQMs reporting solutions, patient safety organization reporting solutions, performance analytics, and clinical risk management solutions. 

The company has a strong presence across the globe mainly in the U.S., Australia, Austria, Belgium, Brazil, Canada, China, Germany, Hungary, India, Ireland, Italy, Japan, and the U.K. Approximately 71% of its revenue is generated from the North American region, but European markets such as Germany, the U.K., France, Italy, and Belgium are expected to offer lucrative growth opportunities in the near future. The company adopts different organic and inorganic growth strategies to strengthen its market position.

Truven Health Analytics is at the second position in the global healthcare quality management market. The company is known for its reputation in healthcare data management and analytics. The solutions offered by Truven are capable of monitoring and conducting real-time clinical observations that help providers minimize risk and deliver patient-specific clinical decision support (CDS) at the point of care. The company’s dominance in the market can be attributed to its wide range of product offerings and its strong geographical footprint. In the U.S., a large number of healthcare providers use Truven’s CareDiscovery Quality Measures to report quality measures

To Know More @ https://www.marketsandmarkets.com/Market-Reports/healthcare-quality-management-market-64588778.html

Scope of Clinical Workflow Solutions Market During 2018-23

 The global clinical workflow solutions market is projected to reach USD 12.1 billion by 2023 from USD 6.8 billion in 2018, at a CAGR of 12.4%. 

Clinical Workflow Solutions Market by Product (Data Integration, EMR Integration, Nurse Call Systems, Unified Communications, Care Solutions, Patient Flow Management, Enterprise Solutions), End Users, and Region - Global Forecast to 2023

The growth of this market is mainly driven by the increase in need to curtail healthcare costs and the increasing patient volume due to the rising prevalence of chronic diseases. Also, the advantages of clinical workflow solutions in enhancing patient care and safety along with the government initiatives for HCIT adoption are escalating the market growth.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146901412

Recent Developments

• In 2018, Infor launched the Healthcare Enterprise Analytics solution and the Infor Cloverleaf Integration Suite 6.2 version.
• In 2016 Cerner opened a Healthe center at the Cerner Center in Bangalore, India, which helped the company enter the Indian market and also expand its geographic reach.
• In 2016, Infor, Adobe, and Topline collaborated to form the H3 Solution, which includes AEM from Adobe, Cloverleaf from Infor, and Codeable LanguageTM from Topline Healthcare.
• In 2015, Cerner acquired the assets of Siemens Health Services, with an aim to expand its market share, enhance its R&D capabilities, and enter into new markets.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/clinical-workflow-solution-market-146901412.html

Particle Counters Market by End User- 2021

The particle counters market is projected to reach USD 330.6 Million by 2021 from USD 275.9 Million in 2016, at a CAGR of 3.7%. other end users

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221564539

On the basis of end user, the particle counters market is segmented into healthcare industry, semiconductor industry, automotive industry, aerospace industry, food and beverage industry, and other end users. 

In 2016, the healthcare industry commanded the largest share of the market. This large share of this segment can be attributed to the rising pharmaceutical industry and increasing R&D expenditure. 

The market for the semiconductor industry is expected to grow at the highest CAGR in the market during the forecast period. Technological advances of semiconductors and rapidly growing Asian market are driving the growth of this industry.

The growth of the market can be attributed to the growing pharmaceutical and semiconductor industries, increasing spending on pharmaceutical R&D, and growing manufacturing industries in emerging nations.

Stakeholders in the Particle Counters Market:

• Particle Counters Manufacturing Companies
• Suppliers and Distributors of Particle Counters
• Healthcare Companies, Automotive Companies, and Semiconductor Companies
• Research and Consulting Firms
• Research Institutes
• Venture Capitalists

To Know More @ https://www.marketsandmarkets.com/Market-Reports/particle-counter-market-221564539.html